Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Mirdametinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 391210-10-9, Pd0325901, Pd 0325901, Pd-0325901, Mirdametinib, (r)-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide
    Molecular Formula
    C16H14F3IN2O4
    Molecular Weight
    482.19  g/mol
    InChI Key
    SUDAHWBOROXANE-SECBINFHSA-N
    FDA UNII
    86K0J5AK6M
    Mirdametinib is an orally bioavailable, synthetic organic molecule targeting mitogen-activated protein kinase kinase (MAPK/ERK kinase or MEK) with potential antineoplastic activity. Upon administration, mirdametinib selectively binds to and inhibits MEK, which may result in the inhibition of the phosphorylation and activation of MAPK/ERK and the inhibition of tumor cell proliferation. The dual specific threonine/tyrosine kinase MEK is a key component of the RAS/RAF/MEK/ERK signaling pathway that is frequently activated in human tumors.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide
    2.1.2 InChI
    InChI=1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m1/s1
    2.1.3 InChI Key
    SUDAHWBOROXANE-SECBINFHSA-N
    2.1.4 Canonical SMILES
    C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O
    2.1.5 Isomeric SMILES
    C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOC[C@@H](CO)O
    2.2 Other Identifiers
    2.2.1 UNII
    86K0J5AK6M
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Mirdametinib

    2. Pd 0325901

    3. Pd 325901

    4. Pd-0325901

    5. Pd-325901

    6. Pd0325901

    7. Pd325901

    2.3.2 Depositor-Supplied Synonyms

    1. 391210-10-9

    2. Pd0325901

    3. Pd 0325901

    4. Pd-0325901

    5. Mirdametinib

    6. (r)-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide

    7. Pd-325901

    8. (r)-n-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)benzamide

    9. Pd 325901

    10. Mirdametinib [usan]

    11. Pd325901

    12. 86k0j5ak6m

    13. Chembl507361

    14. Chebi:88249

    15. Pd 901

    16. N-{[(2r)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

    17. Mirdametinib (usan)

    18. Ncgc00189075-01

    19. Pd 03525901

    20. N-((r)-2,3-dihydroxy-propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide

    21. N-[((r)-2,3-dihydroxypropyl)oxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

    22. N-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide

    23. 391209-97-5

    24. Unii-86k0j5ak6m

    25. N-[(r)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide

    26. 4bm

    27. N-(((r)-2,3-dihydroxypropyl)oxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide

    28. N-((2r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-benzamide

    29. Mirdametinib [inn]

    30. Dsstox_cid_24024

    31. Dsstox_rid_80100

    32. Dsstox_gsid_44024

    33. Mirdametinib [who-dd]

    34. Pd0325901(mirdametinib)

    35. Schembl172904

    36. Gtpl7935

    37. Dtxsid0044024

    38. Ex-a102

    39. Bcpp000126

    40. Bdbm104963

    41. Hms3648a14

    42. Amy36437

    43. Zinc3938683

    44. Tox21_113364

    45. Mfcd09909925

    46. Nsc755770

    47. Nsc800840

    48. S1036

    49. Who 11299

    50. Akos015855518

    51. Bcp9001057

    52. Ccg-221316

    53. Cs-0062

    54. Db07101

    55. Ex-8602

    56. Nsc-755770

    57. Nsc-800840

    58. Ncgc00381744-09

    59. Hy-10254

    60. Us8575391, Q

    61. Bb 0261791

    62. Cas-391210-10-9

    63. Sw218101-2

    64. D11675

    65. Pd-0325901,pd325901

    66. Pd 0325901, >=98% (hplc)

    67. Pd0325901 (pd325901)

    68. Sr-01000946344

    69. J-502503

    70. Sr-01000946344-1

    71. Brd-k49865102-001-01-9

    72. Q27088255

    73. Insolution Mek1/2 Inhibitor Iii, Pd0325901 - Cas 391210-10-9

    74. Benzamide,n-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-

    75. N-((r)-2,3-dihydroxy[propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide

    76. N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)benzamide

    77. N-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- Benzamide

    78. N-[(2r)-2,3-dihydroxypropoxy]-3,4-difluoro-2[(2-fluoro-4-iodophenyl)amino]-benzamide

    79. (-)-n-(((r)-2,3-dihydroxypropyl)oxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide

    80. N-(((r)-2,3-dihydroxypropyl)oxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide N-((2r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 482.19 g/mol
    Molecular Formula C16H14F3IN2O4
    XLogP33
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count7
    Exact Mass481.99504 g/mol
    Monoisotopic Mass481.99504 g/mol
    Topological Polar Surface Area90.8 Ų
    Heavy Atom Count26
    Formal Charge0
    Complexity465
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1